Aquis weekly movers: Wishbone Gold awarded grant for drilling

Wishbone Gold (LON: WSBN) has been granted A$220,000 by the Australian government to help fund the drilling programme for the Cottesloe project in Western Australia. There have been eight priority targets identified. The share price increased 18.9% to 2.2p.

In the first quarter, technology investment company SuperSeed Capital (LON: WWW) grew its NAV by 8% to 105p a share. The share price rose 14.3% to 80p. There is available cash of £310,000. Lower technology company valuations mean that there are plenty of opportunities for investment. Portfolio companies have raised cash at higher valuations, though. The most recent investment was in Kluster Enterprises, which is a revenue analytics and forecasting platform for scaling B2B SaaS companies.

- Advertisement -

Invinity Energy Systems (LON: IES) is supplying nine Invinity VS3 vanadium flow batteries to Orcas Power and Light in the US. Delivery is expected in the first half of 2024. The share price edged up 9.86% to 39p.

Blockchain assets investor KR1 (LON: KR1) announced net assets of £101.2m at the end of April 2023, which is 57.03p a share. The share price improved 7.94% to 34p. There was more than £400,000 of income generated during April. At the end of May, KR1 invested $1m in Aroma, as part of a $25m financing. Aroma is developing technology for building decentralised infrastructure and a related new operating system.

Singer Capital Markets published a new analyst report on wines producer Chapel Down Group (LON: CDGP) and it says that it believes the recent share price decline has been due to a lack of news and it has been overdone. The broker has an estimated NAV of 38p. The share price rose 6.78% to 31.5p. This year’s growing season got off to a good start. A trading update is due in July.  

Hydrogen Future Industries (LON: HFI) chairman Daniel Maling bought 200,000 shares at 6.5p each, taking his stake to 2.51%. The share price moved ahead by 4% to 6.5p.

- Advertisement -

==========

Fallers

Cadence Minerals (LON: KDNC) ASX-listed investee company Hastings Technology Metals says that a model review supports a staged development of the Yangibana rare earths project. That will reduce upfront capital spending and provide a way to reach positive cash flow in the first quarter of 2025. Stage one investment is around $470m. The stage one post-tax NPV11 is $538m. Investee company Evergreen Lithium, which is listed on ASX and Cadence Minerals owns 8.74%, has announced the results of a geochemical programme at the Bynoe lithium project. This has extended the lithium anomalies. There are also indications of other elements. The Cadence Minerals share price dipped 14.1% to 8.55p.

Clarify Pharma (LON: PSYC) reported a reduced annual loss of £1.01m, due to lower admin expenses. There was £435,000 in cash at the end of November 2022, following a cash outflow of £581,000 and net investments of £508,000. The share price fell 4.94% to 0.77p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This

Tagdiv Cloud library - template content.